HighTower Advisors
IBB icon

HighTower Advisors’s iShares Biotechnology ETF IBB Stock Holding History

HighTower Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed -$2K – 3375
2022
Q1 		$2K Buy
+3
New +$391 ﹤0.01% 3340
2017
Q1 		– Sell
-84,000
Closed -$2K – 2121
2016
Q4 		$2K Buy
+84,000
New +$7.65M ﹤0.01% 1909

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

HighTower Advisors's IBB Position: Q2 2026 in Review

HighTower Advisors reduced its iShares Biotechnology ETF (IBB) stake by 35% in Q2 2026, selling an estimated $4.28M and leaving 46,004 shares worth $8.75M. The position accounts for 0.01% of the portfolio, ranked #988.

HighTower Advisors first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $13M in Q1 2019. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • HighTower Advisors held 46,004 shares of iShares Biotechnology ETF worth $8.75M as of Q2 2026.
  • HighTower Advisors sold 24,900 iShares Biotechnology ETF shares in Q2 2026, an estimated $4.28M.
  • iShares Biotechnology ETF made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #988 holding.
  • HighTower Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's iShares Biotechnology ETF position peaked at $13M in Q1 2019.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.